1Y Close · As of Aug 26, 2026
Y-Biologics operates in the Professional Services sector.
Legal name: Y-Biologics, Inc
In fiscal year 2025, Y-Biologics (338840) reported revenue of 2.9 billion KRW, down 49.5% from 5.8 billion KRW a year earlier.
Operating profit was -9.3 billion KRW and net income was -42.0 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 139.5 billion KRW, with a P/B of 5.25.
These figures can be verified in the DART filing (receipt no. 20260323000887).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 2.9B | -9.3B | -42.0B |
| 2024 | 5.8B | -8.4B | -6.4B |
| 2023 | 3.5B | -10.1B | -20.9B |
Recent Filings
Meeting Resolution (Extraordinary Meeting)
Record Date Setting
Derivative Trading Loss
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Meeting Resolution (Extraordinary Meeting) |
| 2026-08-14 | Record Date Setting |
| 2026-08-14 | Derivative Trading Loss |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-05 | Large Shareholding Report (General) |